Journal of Cancer Research and Pharmacology (eISSN: 3115-798X) (J Cancer Res Pharmacol) is a premier international, open-access, peer-reviewed journal dedicated to advancing research at the intersection of oncology and pharmacological sciences. Our mission is to foster innovation in cancer therapeutics by publishing high-quality, cutting-edge research that spans basic science, translational studies, and clinical applications.
Scope
The journal covers a broad spectrum of topics related to cancer biology, drug development, and therapeutic strategies, including but not limited to:
- Cancer Biology & Molecular Mechanisms: Tumorigenesis, metastasis, signaling pathways, and the tumor microenvironment.
- Anticancer Drug Discovery & Development: Novel chemotherapeutic agents, targeted therapies, immunotherapies, and nanomedicine.
- Pharmacology & Drug Delivery: Pharmacokinetics, pharmacodynamics, drug resistance mechanisms, and advanced drug delivery systems.
- Translational & Clinical Research: Biomarker discovery, precision medicine, clinical trial outcomes, and personalized treatment approaches.
- Combination Therapies & Emerging Technologies: Synergistic treatment strategies, repurposed drugs, and innovative technologies (e.g., AI-driven drug design).
Aims
- Disseminate Cutting-Edge Research: Provide a platform for rapid publication of original research, reviews, and perspectives that drive progress in cancer treatment.
- Bridge Bench-to-Bedside Gaps: Promote translational research by integrating preclinical findings with clinical applications.
- Encourage Multidisciplinary Collaboration: Facilitate dialogue among researchers, clinicians, pharmacologists, and biotechnologists to accelerate therapeutic breakthroughs.
- Support Open Science: Ensure global accessibility of research to maximize impact and foster innovation in oncology and pharmacology.
By publishing rigorously vetted, high-impact work, J Cancer Res Pharmacol aims to contribute to the global fight against cancer, ultimately improving patient care and outcomes.
